Credo Diagnostics Biomedical Pte. Ltd., a groundbreaking point-of-care rapid molecular diagnostic company, announced today they will attend the Medlab Middle East exhibition that will take place at the Dubai World Trade Centre from February 3 to February 6.
Credo Diagnostics Biomedical will be showcasing it product line of point-of-care molecular diagnostic solution including the VitaPCR™ platform and Influenza A&B assay, the new QubeMDx+ platform and assays, as well as the upcoming fastest auto-extractor in the world, the Purexon.
Credo Diagnostics Biomedical will be located at the booth #Z4.D29, where they will be meeting with individual practitioners, laboratory technicians, scholars, and potential business partners.
Asian Flush and Easily Drunk: The Genetics of Alcohol Intolerance
March 26, 2025
Can you handle your liquor effortlessly, or do you turn bright red after just one drink? Either way, it’s not unusual—alcohol metabolism varies from person
